Dr. Moss is a Professor of Medicine (Cardiology) and Founding Director of the Heart Research Follow-up Program at the University of Rochester School of Medicine and Dentistry in Rochester, New York. major areas of interest are in genetic and acquired heart rhythm disorders (arrhythmias), acute and chronic coronary heart disease, prevention of sudden cardiac death, clinical trials involving drugs and devices (ICD and CRT).

Former CEO for Diffinity Genomics (developing novel tools for DNA purification) as well as Chiral Quest Corp. Before that as well as BD for Dow Comical and others. 35 years of technical and business leadership in the Biomedical devices community. Was CEO/President of four life-science firms, three of which he co-founded.

Research objective is to elucidate an integrative mechanism by which mitochondria control intracellular Ca2+ homeostasis, energy metabolism, and reactive oxygen species (ROS) generation under both physiological and pathological conditions. Current research effort is to focus on the crosstalk Ca2+ signaling between mitochondria and sarcoplasmic reticulum during excitation-contraction coupling in normal and failing hearts.

J. Montieth “Monty” Estes concentrates his practice on advising emerging technology companies, including high tech start-ups, on legal and business issues, including how to develop and protect their intellectual property assets and how to secure stages of funding.